Chrystyn, H. et al. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim. Care Respir. Med 27, 22 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Labiris, N. R. & Dolovich, M. B. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharm. 56, 588–599 (2003).

Article  CAS  Google Scholar 

Laube, B. L. et al. What the pulmonary specialist should know about the new inhalation therapies. Eur. Respir. J. 37, 1308–1331 (2011).

Article  CAS  PubMed  Google Scholar 

Levy, M. L. et al. Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). NPJ Prim. Care Respir. Med 26, 16017 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Price, D. B. et al. Inhaler errors in the CRITIKAL study: type, frequency, and association with asthma outcomes. J. Allergy Clin. Immunol. Pr. 5, 1071–1081.e1079 (2017).

Article  Google Scholar 

Dhadge, N. et al. Monitoring of inhaler use at home with a smartphone video application in a pilot study. NPJ Prim. Care Respir. Med 30, 46 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Melani, A. S. et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir. Med 105, 930–938 (2011).

Article  PubMed  Google Scholar 

Ovchinikova, L., Smith, L. & Bosnic-Anticevich, S. Inhaler technique maintenance: gaining an understanding from the patient’s perspective. J. Asthma 48, 616–624 (2011).

Article  PubMed  Google Scholar 

Sulaiman, I. et al. Objective assessment of adherence to inhalers by patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med 195, 1333–1343 (2017).

Article  PubMed  Google Scholar 

Sulaiman, I. et al. The impact of common inhaler errors on drug delivery: Investigating critical errors with a dry powder inhaler. J. Aerosol Med Pulm. Drug Deliv. 30, 247–255 (2017).

Article  CAS  PubMed  Google Scholar 

Basheti, I. A., Reddel, H. K., Armour, C. L. & Bosnic-Anticevich, S. Z. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J. Allergy Clin. Immunol. 119, 1537–1538 (2007).

Article  PubMed  Google Scholar 

Harnett, C. M. et al. A study to assess inhaler technique and its potential impact on asthma control in patients attending an asthma clinic. J. Asthma 51, 440–445 (2014).

Article  CAS  PubMed  Google Scholar 

Kocks, J. W. H. et al. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD. NPJ Prim. Care Respir. Med 28, 43 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Usmani, O. S. et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir. Res 19, 10 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Vestbo, J. et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 64, 939–943 (2009).

Article  CAS  PubMed  Google Scholar 

Sanchis, J., Gich, I. & Pedersen, S. Systematic review of errors in inhaler use: Has patient technique improved over time? Chest 150, 394–406 (2016).

Article  PubMed  Google Scholar 

Amin, S., Soliman, M., McIvor, A., Cave, A. & Cabrera, C. Usage patterns of short-acting β(2)-agonists and inhaled corticosteroids in asthma: A targeted literature review. J. Allergy Clin. Immunol. Pr. 8, 2556–2564.e2558 (2020).

Article  Google Scholar 

Azzi, E. A. et al. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta(2) agonists: an Australian community pharmacy-based survey. BMJ Open 9, e028995 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Bloom, C. I. et al. Asthma-related health outcomes associated with short-acting β(2)-agonist inhaler use: An observational UK study as Part of the SABINA Global Program. Adv. Ther. 37, 4190–4208 (2020).

Article  CAS  PubMed  Google Scholar 

Lugogo, N. et al. Real-world patterns and implications of short-acting β(2)-agonist use in patients with asthma in the United States. Ann. Allergy Asthma Immunol. 126, 681–689.e681 (2021).

Article  CAS  PubMed  Google Scholar 

Nwaru, B. I. et al. Overuse of short-acting β(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur. Respir. J. 55, 1901872 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

O’Byrne, P. M. et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N. Engl. J. Med 378, 1865–1876 (2018).

Article  PubMed  Google Scholar 

Quint, J. K. et al. Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America. J. Allergy Clin. Immunol. Pr. 10, 2297–2309.e2210 (2022).

Article  CAS  Google Scholar 

Slejko, J. F. et al. Asthma control in the United States, 2008-2010: indicators of poor asthma control. J. Allergy Clin. Immunol. 133, 1579–1587 (2014).

Article  PubMed  Google Scholar 

Global Initiative for Asthma. Global strategy for asthma management and prevention, https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf (2022).

Bateman, E. D. et al. Short-acting β(2)-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study. Eur. Respir. J. 59, 2101402 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Levy, M. L. The national review of asthma deaths: what did we learn and what needs to change? Breathe (Sheff.) 11, 14–24 (2015).

Article  PubMed  Google Scholar 

Spitzer, W. O. et al. The use of beta-agonists and the risk of death and near death from asthma. N. Engl. J. Med 326, 501–506 (1992).

Article  CAS  PubMed  Google Scholar 

To, T. et al. Is overreliance on short-acting β(2)-agonists associated with health risks in the older asthma population? ERJ Open Res 8, 00032–02022 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Averell, C. M. et al. Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States. Ther. Adv. Respir. Dis. 16, 17534666221116997 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jansen, E. M. et al. Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers. J. Thorac. Dis. 13, 3846–3864 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Cushen, B. et al. The clinical impact of different adherence behaviors in patients with severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med 197, 1630–1633 (2018).

Article  PubMed  Google Scholar 

Hesso, I., Nabhani Gebara, S., Greene, G., Co Stello, R. W. & Kayyali, R. A quantitative evaluation of adherence and inhalation technique among respiratory patients: An observational study using an electronic inhaler assessment device. Int J. Clin. Pr. 74, e13437 (2020).

Google Scholar 

Bosnic-Anticevich, S., Bakerly, N. D., Chrystyn, H., Hew, M. & van der Palen, J. Advancing digital solutions to overcome longstanding barriers in asthma and COPD management. Patient Prefer Adherence 17, 259–272 (2023).

Article  PubMed  PubMed Central  Google Scholar